Share on StockTwits

CSL Limited (ASX:CSL)‘s stock had its “outperform” rating reiterated by equities researchers at Credit Suisse in a research report issued on Thursday. They currently have a $74.55 target price on the stock.

Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank upgraded shares of CSL Limited to a “buy” rating in a research note on Tuesday. They now have a $76.50 price target on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company. CSL Limited has a consensus rating of “Buy” and an average price target of A$74.28 ($69.42).

Shares of CSL Limited (ASX:CSL) traded up 0.92% on Thursday, hitting A$73.400. 2,435,335 shares of the company’s stock traded hands. CSL Limited has a 52 week low of A$63.770 and a 52 week high of A$73.660. The stock’s 50-day moving average is A$67.67 and its 200-day moving average is A$69.07. The company has a market cap of A$34.849 billion and a price-to-earnings ratio of 27.03.

CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.

Receive News & Ratings for CSL Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.